Cargando…

Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C

Cardiorenal syndrome (CRS) is a pathological link between the kidneys and heart, in which an insult in a kidney or heart leads the other organ to incur damage. CRS is classified into five subtypes, and type 3 (CRS3) is characterized by acute kidney injury as a precursor to subsequent cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Neres-Santos, Raquel Silva, Junho, Carolina Victoria Cruz, Panico, Karine, Caio-Silva, Wellington, Pieretti, Joana Claudio, Tamashiro, Juliana Almeida, Seabra, Amedea Barozzi, Ribeiro, César Augusto João, Carneiro-Ramos, Marcela Sorelli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616479/
https://www.ncbi.nlm.nih.gov/pubmed/34831251
http://dx.doi.org/10.3390/cells10113029
_version_ 1784604358548127744
author Neres-Santos, Raquel Silva
Junho, Carolina Victoria Cruz
Panico, Karine
Caio-Silva, Wellington
Pieretti, Joana Claudio
Tamashiro, Juliana Almeida
Seabra, Amedea Barozzi
Ribeiro, César Augusto João
Carneiro-Ramos, Marcela Sorelli
author_facet Neres-Santos, Raquel Silva
Junho, Carolina Victoria Cruz
Panico, Karine
Caio-Silva, Wellington
Pieretti, Joana Claudio
Tamashiro, Juliana Almeida
Seabra, Amedea Barozzi
Ribeiro, César Augusto João
Carneiro-Ramos, Marcela Sorelli
author_sort Neres-Santos, Raquel Silva
collection PubMed
description Cardiorenal syndrome (CRS) is a pathological link between the kidneys and heart, in which an insult in a kidney or heart leads the other organ to incur damage. CRS is classified into five subtypes, and type 3 (CRS3) is characterized by acute kidney injury as a precursor to subsequent cardiovascular changes. Mitochondrial dysfunction and oxidative and nitrosative stress have been reported in the pathophysiology of CRS3. It is known that vitamin C, an antioxidant, has proven protective capacity for cardiac, renal, and vascular endothelial tissues. Therefore, the present study aimed to assess whether vitamin C provides protection to heart and the kidneys in an in vivo CRS3 model. The unilateral renal ischemia and reperfusion (IR) protocol was performed for 60 min in the left kidney of adult mice, with and without vitamin C treatment, immediately after IR or 15 days after IR. Kidneys and hearts were subsequently collected, and the following analyses were conducted: renal morphometric evaluation, serum urea and creatinine levels, high-resolution respirometry, amperometry technique for NO measurement, gene expression of mitochondrial dynamic markers, and NOS. The analyses showed that the left kidney weight was reduced, urea and creatinine levels were increased, mitochondrial oxygen consumption was reduced, NO levels were elevated, and Mfn2 expression was reduced after 15 days of IR compared to the sham group. Oxygen consumption and NO levels in the heart were also reduced. The treatment with vitamin C preserved the left kidney weight, restored renal function, reduced NO levels, decreased iNOS expression, elevated constitutive NOS isoforms, and improved oxygen consumption. In the heart, oxygen consumption and NO levels were improved after vitamin C treatment, whereas the three NOS isoforms were overexpressed. These data indicate that vitamin C provides protection to the kidneys and some beneficial effects to the heart after IR, indicating it may be a preventive approach against cardiorenal insults.
format Online
Article
Text
id pubmed-8616479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86164792021-11-26 Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C Neres-Santos, Raquel Silva Junho, Carolina Victoria Cruz Panico, Karine Caio-Silva, Wellington Pieretti, Joana Claudio Tamashiro, Juliana Almeida Seabra, Amedea Barozzi Ribeiro, César Augusto João Carneiro-Ramos, Marcela Sorelli Cells Article Cardiorenal syndrome (CRS) is a pathological link between the kidneys and heart, in which an insult in a kidney or heart leads the other organ to incur damage. CRS is classified into five subtypes, and type 3 (CRS3) is characterized by acute kidney injury as a precursor to subsequent cardiovascular changes. Mitochondrial dysfunction and oxidative and nitrosative stress have been reported in the pathophysiology of CRS3. It is known that vitamin C, an antioxidant, has proven protective capacity for cardiac, renal, and vascular endothelial tissues. Therefore, the present study aimed to assess whether vitamin C provides protection to heart and the kidneys in an in vivo CRS3 model. The unilateral renal ischemia and reperfusion (IR) protocol was performed for 60 min in the left kidney of adult mice, with and without vitamin C treatment, immediately after IR or 15 days after IR. Kidneys and hearts were subsequently collected, and the following analyses were conducted: renal morphometric evaluation, serum urea and creatinine levels, high-resolution respirometry, amperometry technique for NO measurement, gene expression of mitochondrial dynamic markers, and NOS. The analyses showed that the left kidney weight was reduced, urea and creatinine levels were increased, mitochondrial oxygen consumption was reduced, NO levels were elevated, and Mfn2 expression was reduced after 15 days of IR compared to the sham group. Oxygen consumption and NO levels in the heart were also reduced. The treatment with vitamin C preserved the left kidney weight, restored renal function, reduced NO levels, decreased iNOS expression, elevated constitutive NOS isoforms, and improved oxygen consumption. In the heart, oxygen consumption and NO levels were improved after vitamin C treatment, whereas the three NOS isoforms were overexpressed. These data indicate that vitamin C provides protection to the kidneys and some beneficial effects to the heart after IR, indicating it may be a preventive approach against cardiorenal insults. MDPI 2021-11-05 /pmc/articles/PMC8616479/ /pubmed/34831251 http://dx.doi.org/10.3390/cells10113029 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Neres-Santos, Raquel Silva
Junho, Carolina Victoria Cruz
Panico, Karine
Caio-Silva, Wellington
Pieretti, Joana Claudio
Tamashiro, Juliana Almeida
Seabra, Amedea Barozzi
Ribeiro, César Augusto João
Carneiro-Ramos, Marcela Sorelli
Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title_full Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title_fullStr Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title_full_unstemmed Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title_short Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
title_sort mitochondrial dysfunction in cardiorenal syndrome 3: renocardiac effect of vitamin c
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616479/
https://www.ncbi.nlm.nih.gov/pubmed/34831251
http://dx.doi.org/10.3390/cells10113029
work_keys_str_mv AT neressantosraquelsilva mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT junhocarolinavictoriacruz mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT panicokarine mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT caiosilvawellington mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT pierettijoanaclaudio mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT tamashirojulianaalmeida mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT seabraamedeabarozzi mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT ribeirocesaraugustojoao mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc
AT carneiroramosmarcelasorelli mitochondrialdysfunctionincardiorenalsyndrome3renocardiaceffectofvitaminc